Aquestive Therapeutics, Inc. (AQST) News
Track canonical SquawkNews coverage tagged to AQST, Aquestive Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Aquestive Therapeutics Reports Earnings Miss
Aquestive Therapeutics reports EPS miss by 8c, revenue beat
EARNINGS | Aug 11, 2026, 08:03 PM UTC
L
Aquestive Therapeutics Q2 EPS $(0.18) Misses $(0.12) Estimate, Sales $13.819M Beat $11.418M Estimate
Aquestive Therapeutics Q2 EPS $(0.18) Misses $(0.12) Estimate, Sales $13.819M Beat $11.418M Estimate
EARNINGS | Aug 11, 2026, 08:01 PM UTC
L
AQST - Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
AQST - Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
EARNINGS | Aug 11, 2026, 08:01 PM UTC
L
Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $50.584M Est
Aquestive Therapeutics (NASDAQ: AQST ) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $50.584 million estimate.
EARNINGS | Aug 11, 2026, 08:01 PM UTC
L
AQST - Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conferenc
AQST - Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
EARNINGS | Jul 29, 2026, 11:00 AM UTC